focus -WSS

focus

author：hotspot 2025-09-29 22:47:41 - browse：461

Several amyloid plaques forming between neurons in a brain — Adobe

Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer’s disease treatment from Eisai and Biogen, further clearing the way for what could be the first widely available medicine that delays the disease’s progress.

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval. The agency, which is not required to follow the suggestions of its advisers, is expected to make a final decision on Leqembi by July 6.

“I thought the clinical results were robust,” said Merit Cudkowicz, a neurologist from Massachusetts General Hospital and one of the experts invited to review Leqembi.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Orchard's therapy for neuron disease in children wins FDA approval

focus

WSS

Intermittent fasting comes with a heart risk? Not so fast

Future doctors should be trained to promote social change

Plane’s emergency slide plummets from sky, hits Chicago home

Physicians and social media: If you see something, say something?

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Plane’s emergency slide plummets from sky, hits Chicago home

focus

focus

Wikipedia

Hollywood unions extend contract negotiations for actors

Orchard's therapy for neuron disease in children wins FDA approval

In age of alternative facts, a scholarly course on calling out crap

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Suspected Gilgo Beach killer appeared 'traumatized' after arrest: Defense attorney

Dobbs anniversary: the lost opportunity of abortion as health care

Plastic surgeons increase patient psychiatric screenings

Drug repurposing or repositioning? The language matters

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

leisure time

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

App could help diagnose ear infections more accurately — and at home

AstraZeneca to buy developer of next

Man who had jail sentence commuted by Trump arrested again

India sets sights on home

Celebrate National Dole Whip Day for 3 days this week at Disney

explore

focus

hotspot

hotspot